Table 1.
Author name | Year | Sample size | Study design | Age | Age | Country | Comparators | Dosage/frequency/cycle | Outcomes | Follow-up period | |
---|---|---|---|---|---|---|---|---|---|---|---|
(treatment) | (control) | Suxiao jiuxin pills | Comparators | ||||||||
He | 1995 | 48 | RCT | 42–60 | 40–57 | China | Salvia | 4# tid | 3# tid | Hemorheology | 4 weeks |
| |||||||||||
Song | 1995 | 149 | RCT | 55 ± 7.2 | 56 ± 6.9 | China | Salvia | 5# tid | 3# tid | ECG, blood pressure, and heart rate | 4 weeks |
| |||||||||||
Wang | 1996 | 60 | RCT | NR | NR | China | Shexiang Baoxin pills | 5# tid | 3# tid | ECG and symptom | 2 weeks |
| |||||||||||
Ke | 1996 | 72 | RCT | 45–79 | 46–78 | China | Nitroglycerin | 6# tid | 0.5 mg Q8 h | ECG and symptom | 4 weeks |
| |||||||||||
Gao et al. | 1996 | 147 | RCT | 36–85 | 35–84 | China | Nitroglycerin | 10# | 0.5 mg | ECG and symptom | Immediately |
| |||||||||||
Yun | 1996 | 318 | RCT | 44–76 | 44–75 | China | Isosorbide dinitrate | 6–10# Q4–6 h |
10# tid | ECG and symptom | 2 weeks |
| |||||||||||
Li | 1998 | 154 | RCT | 58.93 ± 10.91 | 59.25 ± 10.12 | China | Isosorbide dinitrate | 0.2 g tid | 10# tid | ECG and symptom | 8 weeks |
| |||||||||||
Feng and Zhou | 2000 | 500 | RCT | 56 ± 4.24 | 55 ± 4.36 | China | Salvia | 10# tid | 10# tid | ECG and symptom, Lipid profile and hemorheology | 4 weeks |
| |||||||||||
Mei | 2000 | 128 | RCT | NR | NR | China | Isosorbide dinitrate | 6# tid | 10# tid | ECG, symptom, and hemorheology | 4 weeks |
| |||||||||||
Xiao | 2000 | 138 | RCT | NR | NR | China | Isosorbide dinitrate | 5# tid | 10# tid | ECG and symptom | 4 weeks |
| |||||||||||
Ru | 2000 | 90 | RCT | 45–70 | NR | China | Salvia | 5# tid | 3# tid | ECG, symptom, lipid profile, and hemorheology | Unclear |
| |||||||||||
Shu | 2000 | 80 | RCT | 58.3 ± 7.24 | 57.2 ± 8.27 | China | Isosorbide dinitrate | 10# tid | 10# tid | ECG and symptom | 4 weeks |
| |||||||||||
Yong | 2000 | 148 | RCT | 45–72 | 47–70 | China | Nitroglycerin | 10# | 5 mg | ECG, Symptom, blood pressure, and heart rate | Immediately |
| |||||||||||
Guang | 2000 | 248 | RCT | NR | NR | China | Isosorbide dinitrate | 5# tid | 10# tid | Blood pressure, heart rate, and lipid profile | 4 weeks |
| |||||||||||
Li | 2000 | 166 | RCT | NR | NR | China | Nitroglycerin | 5# tid | 0.5 mg | ECG and symptom | 2 weeks |
| |||||||||||
Yu | 2000 | 184 | RCT | 40–82 | NR | China | Isosorbide dinitrate | 5# tid | 10# tid | ECG and symptom | 15 days |
| |||||||||||
Ya | 2000 | 60 | RCT | 60–84 | 61–84 | China | Nitroglycerin | 5# tid | 10# tid | ECG and symptom | 4 weeks |
| |||||||||||
Yuan | 2000 | 102 | RCT | 61.68 ± 4.71 | 59.53 ± 5.62 | China | Huoxin pills | 5# tid | 1# tid | ECG, symptom, and lipid profile | 4 weeks |
| |||||||||||
Duan and Yang | 2002 | 80 | RCT | 42–79 | 41–75 | China | Xinkeshu capsule | 5# tid | 4# tid | ECG, UCG, lipid profile, and hemorheology | 4 weeks |
| |||||||||||
Hai | 2002 | 70 | RCT | 57 ± 7 | 59 ± 6 | China | Isosorbide dinitrate | 5# tid | 10# tid | Symptom and hemorheology | 4 weeks |
| |||||||||||
Bu | 2002 | 100 | RCT | 32–72 | NR | China | Isosorbide dinitrate | 4–6# tid | 10–20# tid | ECG and symptom | Unclear |
| |||||||||||
Pei | 2003 | 102 | RCT | 56.1 | 55.2 | China | Nitroglycerin | 5# tid | Unclear | ECG, lipid profile, and hemorheology | 8 weeks |
| |||||||||||
Jin | 2003 | 178 | RCT | NR | NR | China | Isosorbide dinitrate | 5# tid | 20 mg qd | ECG, Symptom, lipid profile, and hemorheology | 6 weeks |
| |||||||||||
Ma | 2004 | 116 | RCT | 63.4 ± 6.74 | 62.9 ± 7.84 | China | Salvia | 10# tid | 3# tid | ECG, symptom, and hemorheology | 4 weeks |
| |||||||||||
Pei | 2004 | 100 | RCT | 57.5 ± 10.2 | 63.1 ± 7.9 | China | Xinkeshu capsule | 6# tid | 4# tid | ECG and symptom | 4 weeks |
| |||||||||||
Yue | 2004 | 78 | RCT | 52–75 | 55–74 | China | Placebo | 5# tid | 10# tid | ECG, UCG, and symptom | 4 weeks |
| |||||||||||
Hu | 2004 | 80 | RCT | 51.56 ± 11.69 | 50.89 ± 11.02 | China | Nitroglycerin | 10# tid | 0.5 mg tid | ECG and symptom | 24 weeks |
| |||||||||||
Zhu | 2005 | 199 | RCT | 61.8 | 59.5 | China | Glucose-insulin-potassium therapy | 4–6# tid | Q2 d | ECG, symptom, and lipid profile | 15 days |
| |||||||||||
Wan | 2005 | 64 | RCT | NR | NR | China | Hesu pills | 5# tid | 1# tid | ECG and symptom | 2 weeks |
| |||||||||||
Shui | 2006 | 73 | RCT | 43–78 | 45–76 | China | Salvia | 10# tid | 10# tid | ECG and lipid profile | 8 weeks |
| |||||||||||
Cao and Zhang | 2007 | 187 | RCT | 57.15 ± 5.38 | 58.77 ± 5.01 | China | Salvia | 6# tid | 6# tid | ECG and symptom | 2 weeks |
| |||||||||||
Run | 2007 | 90 | RCT | NR | NR | China | Isosorbide dinitrate | 10–15# | 10 mg | ECG and symptom | Immediately |
| |||||||||||
Wang | 2008 | 60 | RCT | 63.9 ± 12.1 | 64.1 ± 11.2 | China | Shexiang Baoxin pills | 5# tid | 1# tid | ECG and symptom | 2 weeks |
| |||||||||||
L. Wen | 2009 | 88 | RCT | 56.7 | 56.8 | China | Isosorbide dinitrate | 5# tid | 10# tid | ECG and symptom | 8 weeks |
| |||||||||||
Feng | 2009 | 900 | RCT | NR | NR | China | Salvia | 6# tid | 3# tid | ECG and symptom | 4 weeks |
| |||||||||||
S. L. Wen | 2009 | 50 | RCT | NR | NR | China | Tongxinluo pills | 5# tid | 4# tid | ECG and symptom | 2 weeks |
| |||||||||||
Guo | 2012 | 60 | RCT | 42–70 | 43–73 | China | Salvia | 5# tid | 3# tid | UCG and hemorheology | 2 weeks |
| |||||||||||
Qiao | 2012 | 300 | RCT | 39–82 | 40–81 | China | Salvia | 5# tid | 3# tid | ECG and symptom | 4 weeks |
| |||||||||||
Xin | 2013 | 289 | RCT | 58.86 ± 10.57 | 57.69 ± 9.93 | China | Standard therapy | 10# tid | Blank | ECG and symptom | 2 weeks |
| |||||||||||
Long | 2013 | 120 | RCT | 43–68 | 42–67 | China | Standard therapy | 10# tid | Blank | ECG and symptom | 2 weeks |
| |||||||||||
Li | 2015 | 100 | RCT | 44–75 | 45–76 | China | Salvia | 6# tid | 3# tid | ECG and symptom | 4 weeks |
NR: not reported; RCT: randomized controlled trial; tid: three times a day; Q4–6 h: every 4–6 h; Q8 h: every 8 h; ECG: electrocardiograph; UCG: ultrasound cardiogram; #: tablet.